Searchable abstracts of presentations at key conferences in endocrinology

ea0049oc12.3 | Pituitary Clinical | ECE2017

Recombinant Growth Hormone added to physical therapy in GH-deficient adults with complete (ASIA A) Spine Injury (EudraCT 2011-005377-23)

Cuatrecasas Guillem , Kumru Hatice , Coves M°Josep , Patrascioiu Ioana , Vidal Josep

Introduction: Although in-vitro models suggest GH-induced differentiation, migration and survival of astrocytes and oligodendrocytes, no studies had been published in-vivo. We want to evaluate the efficacy and safety of GH associated with physical therapy compared to placebo in patients with complete spine injury (SI) and associated GH deficiency (GHD).Methods: Eighteen Patients with complete SI were screened for GHD (glucagon test). 12 severe (...

ea0056p600 | Obesity | ECE2018

Obesity and dementia: the misleading “obesity paradox”

Pane Adriana , Pegueroles Jordi , Ruiz Sabina , Videla Laura , Carmona-Iragui Maria , Vilaplana Eduard , Montal Victor , Casajoana Anna , Vidal Josep , Fortea Juan , Jimenez Amanda

Background: Mid-life obesity is a risk factor for Alzheimer’s disease (AD). On the contrary, late-life obesity has been identified as a protective factor for dementia. Recent published studies have shown that weight loss predicts and precedes dementia diagnosis by decades. Thus, paradoxical effect of body weight across lifespan, the so called “obesity paradox”, might be explained by reverse causality. Structural magnetic resonance imaging (MRI) has been extensiv...